#LyraTherapeutics $LYRA chart is starting to look good.

A starter position here would be ideal, with more buys around $4.00/share and again around $4.50/share.

First PT is $5.00 then $7.00 though biotech stocks are notoriously volatile so always do your own due diligence.

Set

We're excited to be in our new headquarters and manufacturing facility in Waltham, MA! #chronicrhinosinusitis

lyratherapeutics.com

Today, we announced our Q3 2023 Financial Results and provided a corporate update.
investors.lyratherapeutics.com/news-releases/…

$LYRA Clean data:
investors.lyratherapeutics.com/static-files/8…

Ongoing cc:
edge.media-server.com/mmc/p/xfx5b2kt/

Lyra Therapeutics reports disappointing results for LYR-210 in Phase 3 chronic rhinosinusitis trial business-news-today.com/lyra-therapeut… #LyraTherapeutics #ChronicRhinosinusitis #ClinicalTrials #HealthcareNews #LYR210

We're pleased to announce the appointment of Ronan O’Brien as Lyra's Chief Legal Officer. He brings more than 25 years of legal experience to Lyra, with expertise that will be key as Lyra evolves from a clinical enterprise into a commercial one.
investors.lyratherapeutics.com/news-releases/…

Today our CEO Maria Palasis participated in a fireside chat at the William Blair Virtual Biotech Focus Conference in New York. Access the replay here:
investors.lyratherapeutics.com

🧵 Biopharma Downsizing Trends 2024: Major Companies Adjusting Workforce
#Biopharma #Layoffs #Downsizing #WorkforceReduction #Evotec #LyraTherapeutics #TakedaPharmaceuticals #IndustryTrends #

Today our President & CEO Maria Palasis will participate in a fireside chat at the Jefferies London Healthcare Conference. The webcast will be available on our Investors page:
investors.lyratherapeutics.com/news-and-event…

Today our President & CEO Maria Palasis will give a presentation at the Piper Sandler 35th Annual Healthcare Conference. The webcast will be available on our Investors page:
investors.lyratherapeutics.com/news-and-event…

#LyraTherapeutics $LYRA is up +29% since this post 3 days ago.

More buying was recommended at $4.00/share.

Waiting to see when we reach our first #PriceTarget of $5.00/share.

Today our President & CEO Maria Palasis presented at the Jefferies Healthcare Conference. The webcast will be available on our Investors page:
investors.lyratherapeutics.com/news-and-event…

$LYRA vs. $Z: which stock is the best to buy? #LyraTherapeutics srnk.us/go/4726743

Spontonic there is no direct comparison. One uses an external device , one uses an internally placed stent to deliver the drug.
$OPTN ir.optinose.com/static-files/b…
$LYRA investors.lyratherapeutics.com/static-files/d…
Both with rising fund interest.

Lyra Therapeutics Inc ( $LYRA)
$3.50 +0.47 (+15.51%) 09:54 ET [NASDAQ]

Announces Restart of Pivotal Phase 3 ENLIGHTEN II Clinical Trial of LYR-210 in Chronic Rhinosinusitis

finance.yahoo.com/news/lyra-ther…

investors.lyratherapeutics.com/static-files/d…

What stocks might make more money? Compare $LYRA vs. $Z. #LyraTherapeutics srnk.us/go/4731152

What is the difference between $LYRA and $X? Learn it. #LyraTherapeutics srnk.us/go/4478608

If you have $LYRA or $Z in your portfolio, pay attention! #LyraTherapeutics srnk.us/go/4742246

Which stock is the best to invest? Compare $LYRA vs. $PMVP. #LyraTherapeutics srnk.us/go/4378375

$LYRA vs. $PMVP: what is the best stock to add to your portfolio? #LyraTherapeutics srnk.us/go/4381970